Remarkable characterization and determination of atypical E. coli O157 none producing shiga toxin which can produce cytopathic effect on Vero cell and diarrhea in mice


Keywords:
E. coli O157 Shiga toxin Cytopathic effect Vero cell Diarrhea Mice
M. MOSHIRI
Y. TAHAMTAN
M. NAMAVARI
Abstract

This study focused on the cytopathic effect of an unusual form of E. coli O157:H7 (atypical E. coli O157 (a-O157)) on Vero cell and infant mice. Multiplex PCR assay showed that they did not carry the gene for either shiga toxin 1 (stx1) or stx2 and other virulence factors. Increased changes in epithelial cell morphology, inter and intracellular gap junction and invading were assessed using Vero assay. In addition, a-O157infection causes disruptions of intercellular tight junctions, leading to clinical sequelae that include acute diarrhea in mice. Vero cell monolayers were exposed to a-O157influx and disintegrated tight junction of Vero cell line. Infected Vero cell enhance the number of attaching and effacing (A/E) lesions. Collectively, these findings provide in vitro evidence that Vero cell infected by a-O157was shown injury in epithelial cell barrier and induced A/E lesion the same as E. coli O157:H7 stx positive. These variants cannot be diagnosed by routine monitoring methods like biochemical assay for E. coli O157:H7 stx positive control. Finally, the data suggest that not only typical but also a-O157are an important cause of diarrhea in mice and produce cytopathic effect on Vero cell and may be harmful for food animal and also human.

Article Details
  • Section
  • Research Articles
Downloads
Download data is not yet available.
References
Allerberger F , Dierich M P , Gruber-Moesenbacher U , Liesegang A , Prager R. Nontoxigenic sorbitol-fermenting Escherichia coli O157:H2 associated with a family outbreak of diarrhea. Wien Klinische Wochens 2000: 112, 846-50.
Bielaszewska M , Prager R , Kock R , Mellmann A , Zhang W. Shiga Toxin Gene Loss and Transfer In Vitro and In Vivo during Enterohemorrhagic Escherichia coli O26 Infection in Humans. App Environ Microbiol 2007: 73, 3144-50.
Brussow H , Canchaya C , Hardt W D. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Molecul Biol Rev 2004: 68, 560-602.
CCID. Coordinating Center for Infectious Diseases / Division of Bacterial and Mycotic Diseases “Escherichia coli O157:H7”, 2006, September 24.
Feng P , Dey M , Abe A , Takeda T. Isogenic Strain of Escherichia coli O157:H7 That Has Lost both Shiga Toxin 1 and 2 Genes. Clin Diagnos Lab Immun 2001: 8, 711-17.
García A, Bosques C J, Wishnok J S. Renal injury is a consistent finding in Dutch Belted rabbits experimentally infected with enterohemorrhagic Escherichia coli. J Infec Dis 2006: 193, 1125–1134.
Garcia-Aljaro C , Muniesa M , Jofre J , Blanch A R. Newly identified bacteriophages carrying the stx2g gene isolated from Escherichia coli strains in polluted waters. FEMS Microbiol Lett 2006: 258, 127-35.
Garcia-Aljaro C, Muniesa M , Jofre J , Blanch A R. Genotypic and Phenotypic Diversity among Induced, stx2-Carrying Bacteriophagesfrom Environmental Escherichia coli Strains. App Environ Microbiol 2009: 75, 329-36.
Gyles C L. Shiga toxin-producin Escherichia coli: an overview. J Anim Sci 2007: 85, E45-E62.
Karch H , Bielaszewska M. Sorbitol-Fermenting Shiga Toxin-Producing Escherichia coli O157:H2 Strains: Epidemiology, Phenotypic and Molecular Characteristics, and Microbiological Diagnosis. J Clin Microbiol 2001: 39, 2043-9.
Karch H , Tarr P , Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol2005: 295, 405-18.
Kudva I T , Griffin R W , Murray M , John M , Perna N T. Insertions, Deletions, and Single-Nucleotide Polymorphisms at Rare Restriction Enzyme Sites Enhance Discriminatory Power of Polymorphic Amplified Typing Sequences, a Novel Strain Typing System for Escherichia coli O157:H7. J Clin Microbiol 2004: 42, 2388-97.
Melton-Celsa A, O’brien A D, Feng P CH. Virulence Potential of Activatable Shiga Toxin 2d–Producing Escherichia coli Isolates from Fresh Produce. J Food Protect 2015: 78, 2085-2088.
Mohawk K L, Melton-Celsa AR, Zangari T, Carroll E E, O’Brien A D. Pathogenesis ofEscherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora. Microb Pathogen 2010: 48131–142.
Paton A W and Paton J C. Escherichia coli Subtilase Cytotoxin. Toxins 2010: 2, 215-228.
Pierard D, De Greve H, Haesebrouck F Mainil J. O157:H7 and O104:H4 Vero/Shiga toxinproducing Escherichia coli outbreaks: respective role of cattle and humans. Vet Res 2012: 43,13-17.
Riley L W , Remis R S , Hel--gerson S D , McGee H B , Wells J G. Hemorrhagic colitis associated with a rare Escherichia coli serotype. New Eng J Med 1983, 308, 681-5.
Schmidt H , Scheef J , Huppertz H , Frosch M , Karch H. Escherichiacoli O157:H7 and O157:H2 strains that do not produce Shiga toxin: phenotypic and genetic characterization of isolates associated with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol 1999, 37,3491-6.
Tahamtan Y , Kargar M , Namdar N , Rahimian A , Hayati M , Namavari M M. Probiotic inhibits the cytopathic effect induced by Escherichia coli O157:H7 in Vero cell line model. Lett App Microbiol 2011, 52,527-31.
Tahamtan Y, Namavari MM. Prevalence of O157:H7 and Non-O157:H7in Iranian domestic sheep. Pakistan J Biolog Sci 2014, 17: 104-108.
Whitworth J H , Fegan N , Keller J , Gobius K S , Bono J L. InternationalComparison of Clinical, Bovine, and Environmental Escherichia coli O157 Isolates on the Basis of Shiga Toxin-Encoding Bacteriophage Insertion Site Genotypes. Applied and Environment Microbiology 2008: 74, 7447-50.
Zotta E, Lago N, Ochoa F, Repetto H A, and Ibarra C. Development of an experimental hemolytic uremic syndrome in rats. Pediat Nephrol 2008: 23, 559–567.
Most read articles by the same author(s)